Comparison between the neurotoxic and serotonin-depleting effects of various halogenated derivatives of amphetamine in the rat.
D000662:Amphetamines / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000378:metabolism; D001927:Brain Diseases / Q000139:chemically induced* / Q000473:pathology; D005277:Fenfluramine / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000494:pharmacology; D006651:Histocytochemistry; D008297:Male; D009474:Neurons / Q000473:pathology; D010647:Phenyl Ethers / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000378:metabolism*
D000662:Amphetamines; D010647:Phenyl Ethers; D011437:Propylamines; D005277:Fenfluramine; D012701:Serotonin